Highly multiplexed imaging by Cyclic Immunofluorescence (CycIF) of protein levels and protein phosphorylation states in the COLO 858 melanoma cell line - Dataset (ID:20236)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Timepoint Timepoint Unit Raw Image Registered Image CycIF Round Primary Antibody Secondary Antibody Cytell filter Protein Detected Other Reagent Detected Measured Fluorescence Intensity (a.u.) Field Cell ID Number X-coordinate Y-coordinate Cell Area (um^2) Cell Perimeter (um) Cell Circularity
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 4472.7 4
0106-0245
716.17 245.07 436 77.60 0.910
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3057.8 4
0107-0247
327.17 247.13 466 82.43 0.862
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1056.4 4
0108-0246
134.48 245.89 176 49.36 0.908
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 499.4 4
0109-0253
433.59 253.15 267 60.77 0.909
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1878.8 4
0110-0253
587.73 252.99 305 65.01 0.907
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 379.7 4
0111-0256
80.26 256.04 257 61.36 0.858
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 5363.1 4
0112-0257
247.39 255.62 261 61.60 0.864
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2345.7 4
0113-0256
364.30 256.01 292 63.94 0.897
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1365.0 4
0114-0254
936.70 254.54 298 65.36 0.877
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 626.3 4
0115-0257
755.30 256.76 273 62.43 0.880
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 650.6 4
0116-0257
864.11 257.95 306 66.77 0.863
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 4165.6 4
0117-0258
384.05 257.99 249 58.28 0.921
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 2561.6 4
0118-0260
777.97 259.88 263 59.94 0.920
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 351.5 4
0119-0265
223.78 265.45 272 63.94 0.836
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1340.6 4
0120-0264
502.47 264.27 314 66.43 0.894
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3224.2 4
0121-0265
114.70 264.56 274 62.77 0.874
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 745.8 4
0122-0271
280.71 271.29 271 61.36 0.905
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 421.2 4
0123-0271
834.78 271.50 274 61.01 0.925
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 1053.9 4
0124-0274
894.80 274.10 305 65.60 0.891
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3226.6 4
0125-0278
522.30 279.48 304 69.01 0.802
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 507.8 4
0126-0276
602.65 276.21 294 62.77 0.938
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 3093.4 4
0127-0284
128.97 286.07 617 101.40 0.754
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 5031.5 4
0128-0277
254.08 276.78 243 59.36 0.867
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 336.0 4
0129-0286
42.86 285.69 296 64.43 0.896
COLO 858 Vemurafenib
0.0316
uM
48
hr
image if available image if available
Cycle-1
KI-67 / clone D3B5 rabbit IgG(H+L) / goat / cross-adsorbed
FITC
KI-67 395.4 4
0130-0286
158.65 286.05 218 55.70 0.883